Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EI7H
|
|||
| Former ID |
DIB003056
|
|||
| Drug Name |
ThromboMer
|
|||
| Synonyms |
TPO peptide mimetic (thrombocytopenia), AplaGen; Thrombopoietin peptide mimetic (thrombocytopenia), AplaGen
Click to Show/Hide
|
|||
| Indication | Thrombocytopenia [ICD-11: 3B64] | Investigative | [1] | |
| Company |
AplaGen GmbH
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thrombopoietin receptor (MPL) | Target Info | Modulator | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| WikiPathways | Platelet Aggregation (Plug Formation) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1722). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.